Gain Therapeutics Current Assets

Gain Therapeutics (GANX) currently reports a current assets of $15M as of June 2026. That compares with $9.3M in the prior-year period — up 60.8% year over year. Use the charts on this page to explore Gain Therapeutics's current assets history and peer comparisons.

Gain Therapeutics's current assets increased from $9.3M to $15M — a 60.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gain Therapeutics reported $15M in current assets as of June 2026. That compares with $9.3M in the prior-year period — up 60.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gain Therapeutics, and consider following GANX for alerts when major investors trade the stock.

Gain Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GANX with unrelated industries.